REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Silicon Containing Doai Silicon Containing DoaiSilicon Containing Doai patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070021386 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced ... 01/25/07 - 20070021385 - Compositions and methods for wood preservation Provided is a composition and method for the preservation of wood. The composition comprises 1) an azole and/or quaternary ammonium compound component and 2) a pyrethroid compound component such that wood treated with the composition has a greater decay resistance than wood treated to the same azole retention with the ... 01/25/07 - 20070021384 - Compounds for use in the treatment of infection in which each of R8 to R10 is hydrogen, aryl, C1-6 alkyl, trialkylsilyl or acyl; R1 to R5 are individually selected from hydrogen, hydroxy, C1-6 alkoxy and acyloxy; R6 and R7 are H, C1-4 alkyl, trialkylsilyl or acyl; X is O or NR, and R is H or Me; in ... 01/25/07 - 20070021383 - Organosilane quaternaries for acaricidal activity A method for killing acarids on a surface is disclosed. The method includes applying a solution comprising an organosilane quaternary compound to the surface such that the surface is wet. In one example, the compound comprises an organosilane quaternary such as 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride. In another example, the solution further ... 01/25/07 - 20070021382 - Nitric oxide donors and uses thereof Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, ... 01/18/07 - 20070015730 - Peripherally-selective inhibitors of dopamine-ß-hydroxylase and method of their preparation where R1, R2 and R3 are the same or different and signify hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; R4 signifies hydrogen, alkyl or alkylaryl group; X is CH2, O or S, and n is 1, 2 or 3, with the proviso that if ... 01/11/07 - 20070010488 - Compounds for modulating cell proliferation Compounds that modulate cell proliferation are taught. These compounds are useful as inhibitors of abnormal cell proliferation. ... 01/04/07 - 20070004675 - Inhibitors of vegf receptor and hgf receptor signaling The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions ... 01/04/07 - 20070004674 - Remedy for diseases associated with immunoglobulin gene translocation A medicament comprising a compound having an inhibitory action on Hsp90 or a pharmaceutically acceptable salt thereof as an active ingredient is used as a therapeutic agent for diseases associated with immunoglobulin gene translocations. In diseases associated with immunoglobulin gene translocations, abnormal enhancement of the expression of a partner gene ... 12/28/06 - 20060293281 - N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments. ... 12/28/06 - 20060293280 - 1,3-oxathiolane-2-thione compounds wherein R1 and R2 are the same or different, each of which denotes a straight-chain or branched alkoxy residue with 1 to 6 carbon atoms or an aryloxy or aralkyloxy residue, R3 is different or the same as R1 or R2 or an aliphatic residue, an amino residue, a halogen ... 12/07/06 - 20060276434 - 3-carbonylaminothiophenes and their use as fungicides The invention also relates to novel compounds of formula (I) where Het is a 5- or 6-membered heterocyclic ring containing one to three heteroatoms, each independently selected from oxygen, nitrogen and sulphur, the ring being substituted by one to three groups R4; R1 is hydrogen, optionally substituted (C1-4)alkyl, formyl, optionally ... 12/07/06 - 20060276433 - Hydrazone derivative wherein R1 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R2 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R3 ... 11/30/06 - 20060270628 - Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them The present invention relates to novel triazole compounds of formula (I), thie pharmaceutically acceptable salts and their pharmaceutical compositions, where all symbols have meaning as defined in the description, for use in the treatment of bacterial infections. ... 11/16/06 - 20060258620 - Novel method for the asymmetric synthesis of beta-lactone compounds The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These ... 11/16/06 - 20060258619 - Silicon containing compounds having selective cox-2 inhibitory activity and methods of making and using the same Silicon-containing compounds having selective COX-2 inhibitory activity, as well as compositions thereof are provided. The subject compounds find use in a variety of applications, including therapeutic applications. Also provided are kits containing the subject compounds and pharmaceutical preparations thereof. ... 11/16/06 - 20060258618 - Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs 3,5-di-substituted-4-hydroxybenzylidene phosphonates and sulfonates useful in treating inflammatory disease, particularly osteoarthritis, and elastomeric particles for oral delivery of drugs are disclosed. ... 10/05/06 - 20060223782 - 2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1alpha-hydroxyvitamin d3-26,23-lactone Compounds of formula 1A and 1B are provided where X1 and X2 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological disorders. ... 09/28/06 - 20060217346 - Fungicides The use as a plant fungicide of a compound of general formula (1). Also included are plant fungicidal compositions containing these compounds and some of the compounds themselves. ... 08/31/06 - 20060194764 - Biocides based on silanol terminated silanes and siloxanes A method of destroying target microorganisms comprises the step of contacting at least one target microorganism with at least one low molecular weight silanol end group containing molecule. The silanol containing molecule is selected from silanols (R1R2R3SiOH), siloxanediols HO(R1R2SiO)nH or siloxanols HO(R1R2SiO)nSiR1R2R3, where R1, R2 and R3 are selected from ... 08/31/06 - 20060194763 - N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides Fungicidal compounds of the general formula (1) wherein X, Y, Z, R1, R2, R3, R4 and R5 have the definitions given in claim 1. ... 08/24/06 - 20060189578 - Method for the synthesis of compounds of formula i and their uses thereof This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated ... 08/24/06 - 20060189577 - Tyrosine kinase inhibitors The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a substituted pyrrole moiety. The present invention is also related to the pharmaceutically acceptable ... 08/24/06 - 20060189576 - Substituted vitamin d analogues and their therapeutic uses The present invention relates to analogues of vitamin D namely 14-epi-2-alkyl-19-nor vitamin D derivatives. Also a general method for the synthesis and the biological activities are described. The general formula is: (I) where R (α or β oriented) represents an alkyl substituent and X part of a typical side chain ... 08/17/06 - 20060183716 - 2-methylene-19-nor-(20s-24s)-1alpha,25-dihydroxyvitamin d2 Compounds of formula I are provided where X1, X2, and X3 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions. ... 07/27/06 - 20060166933 - Novel 2h-chromene derivatives as selective estrogen receptor modulators The present invention is directed to novel 2H-chromene derivatives, pharmaceutical compositions containing them, their use in the treatment of disorders mediated by one or more estrogen receptors and processes for their preparation. ... 07/20/06 - 20060160770 - Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds with a compound such as R1OH or R1SH, to produce said compound of Formula I. Compounds of Formula I are useful, among other things, as dyes, spectral sensitizers, glycosidase inhibitors, and as antibacterial, antiviral, and anti-inflammatory agents. ... 07/20/06 - 20060160769 - 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses This invention discloses 2α-methyl-19-nor-(20S)-vitamin D analogs, and specifically 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as ... 07/06/06 - 20060148760 - Method for the sysnthesis of compounds of formula i and their uses thereof This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated ... 07/06/06 - 20060148759 - 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses This invention discloses 2α-methyl-19-nor-vitamin D analogs, and specifically 2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as ... 06/29/06 - 20060142247 - Tricyclic heterocycles their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer. ... 06/29/06 - 20060142246 - 2-methylene-19,26,27-trinor-(20s)-1alpha-hydroxyvitamin d3 and its uses This invention discloses 2-methylene-19,26,27-trinor-(20S)-vitamin D analogs, and specifically 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis ... 06/29/06 - 20060142245 - Inhibitors of hedgehog signaling pathways, compositions and uses related thereto The present invention makes availables assays and reagents inhibiting paracrine and/or autocrine signals produced by a hedgehog protein or aberrant activation of a hedgehog signal transduction pathway, e.g., which involve the use of a steroidal alkaloid or other small molecule. ... 06/22/06 - 20060135477 - Compositions for injectable ophthalmic lenses Injectable ophthalmic compositions suitable for forming an intraocular lens in the capsular bag of an eye comprise linear non-functional polysiloxane, linear terminally functional polysiloxane, and at least one crosslinker. The linear terminally functional polysiloxane may comprise a mixture of linear terminally monofunctional polysiloxane and linear terminally di-functional polysiloxane. ... 06/15/06 - 20060128661 - Novel substituted 1h-pyrrolo[2,3-b]pyridines and preparation thereof to processes for their preparation and to intermediates therefor. ... 06/15/06 - 20060128660 - Fk228 analogs and methods of making and using the same The present invention provides FK228 analogs and methods of making and using the same. Such analogs are potent inhibitors of histone deacetylase and, in certain embodiments, are capable of specifically targeting cancerous cells and tissues. In preferred embodiments, these analogs are characterized by a cyclic disulfide design. ... 06/01/06 - 20060116352 - 2alpha-methyl and 2beta-methyl analogs of 19,26,27-trinor-(20s)-1alpha-hydroxyvitamin d3 and their uses This invention discloses 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S) -1α-hydroxyvitamin D3 and pharmaceutical uses therefor. These compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as ... 06/01/06 - 20060116351 - 17,20(z)-dehydro vitamin d analogs and their uses This invention discloses 17,20(Z)-dehydro vitamin D analogs, and specifically 17(Z)-1α,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3 and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as ... 05/25/06 - 20060111323 - Use of polysiloxanes having quaternary ammonium groups as formulation auxiliaries, and compositions comprising them The present invention relates to the use of polysiloxanes containing at least one quaternary ammonium group as formulation auxiliaries in formulations of pharmaceutically and veterinary active compounds, and to compositions comprising a) a pharmaceutically or veterinary active compound and b) a polysiloxane derivative containing at least one quaternary ammonium group ... 05/25/06 - 20060111322 - Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation The invention is directed to intermediates useful for making indazole compounds that modulate and/or inhibit cell proliferation. ... 05/25/06 - 20060111321 - 2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses This invention discloses 2-methylene-19-nor-17-ene vitamin D analogs, and specifically 2-methylene-19-nor-α-hydroxy-17-ene-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis ... 05/25/06 - 20060111320 - Fungicidal mixtures based on a triazolopyrimidine derivative and azoles Disclosed are fungicidal mixtures containing A) a triazolopyrimidine derivative of formula (1), and B) an azole derivative or the salts or addition compound thereof selected among bromuconazole, difenoconazole, diniconazole, fenbuconazole, fluquinconazole, flusilazole, hexaconazole, prochloraz, tetraconazole, triflumizole, flutriafol, myclobutanil, penconazole, simeconazole, ipconazole, triticonazole, and prothioconazole as active components in a synergistically ... 05/18/06 - 20060105994 - Treatment of prostate cancer A chemical agent of the diterpene family obtained from a member of the Euphorbiaceae family of plants for use in the treatment of prophylaxis of prostate cancer or a related cancer or condition. ... 05/04/06 - 20060094692 - Pharmaceutical formulations of camptothecins and process for making same This invention relates to pharmaceutically elegant formulations of highly lipophilic camptothecin derivatives. ... 03/16/06 - 20060058264 - Opioid receptor ligands and methods for their preparation that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. The invention also provides an improved method for isolating intermediate materials useful for ... 03/09/06 - 20060052344 - Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone) A compound of formula (I) wherein one of X and Y is silicon, and the other is carbon or silicon; Z is oxygen, sulphur or —N(R)—, wherein R is hydrogen or alkyl; R1 is hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxy or cycloalkyl; and R2 is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, ... 03/09/06 - 20060052343 - Anthranilamide insecticides wherein A is O or S(O)?m#191;J is a phenyl or heterocyclic ring as defined herein; and R1 through R12, n, m and r are as defined in the disclosure. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective ... 03/02/06 - 20060046977 - Furanopyridine derivatives and methods of use and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula I, methods of modulating Lck and ACK-1 enzymes and of treating various related diseases and conditions, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ... 02/23/06 - 20060040897 - Compositions for treating and/or preventing diseases characterized by the presence of metal ions The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some ... 02/02/06 - 20060025383 - Aminobenzoxazoles as therapeutic agents wherein the substituents are as defined herein, which are useful as kinase inhibitors. ... 01/05/06 - 20060003966 - Carbazole formulations for the treatment of psoriasis and angiogenesis The methods and compositions disclosed herein relate to using carbazole, and derivatives thereof to modify a signaling activity such as epidermal growth factor receptor (EGFR) signalling, and angiogenesis activity, in a cell. ... 11/24/05 - 20050261244 - Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity. ... 11/17/05 - 20050256085 - Fungicidal mixtures in a synergistically effective amount, methods for controlling harmful fungi using mixtures of the compounds I and II and the use of the compounds I and II for preparing such mixtures are described. ... 11/10/05 - 20050250741 - Novel indole derivatives as selective androgen receptor modulators (sarms) The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. ... 11/10/05 - 20050250740 - Novel indole derivatives as selective androgen receptor modulator (sarms) The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. ... 11/03/05 - 20050245485 - Novel indole derivatives as selective androgen receptor modulators (sarms) The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. ... 10/20/05 - 20050234019 - Arginine silicate inositol complex and use thereof A method for preventing and treating a variety of disease states and disorders is provided, comprising the administration of an arginine silicate inositol complex to an individual in the presence of medical therapy or absence of medical therapy. Examples of said disease states and disorders include bone and cartilage disorders ... 10/06/05 - 20050222089 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor The present invention generally relates to at least one precursor compound and derivatives thereof, a process for preparing a taxane, and a baccatin derivative. ... 10/06/05 - 20050222088 - Synthesis of chiral furan amino acids as novel peptide building blocks The present invention provides a chiral furan amino acids, in enantiomerically pure forms, either R or S. The starting materials are being used chiral N-terminal-protected amino aldehydes derived from the corresponding N-terminal-protected protected L- or D-amino acids. The present invention also relates to a process for preparing these chirally substituted ... 10/06/05 - 20050222087 - Modulators of hedgehog signaling pathways, compositions and uses related thereto The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway ... 09/22/05 - 20050209192 - Therapeutic agents - ii The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides ... 09/22/05 - 20050209191 - 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof The present invention relates to 1-aza-dibenzoazulene derivatives, to their pharmacologically acceptable salts and solvates, to processes and intermediates for the preparation thereof as well as to their antiinflammatory effects, especially to the inhibition of tumour necrosis factor-α (TNF-α) production and the inhibition of interleukin-1 (IL-1) production as well as to ... 09/15/05 - 20050203063 - Proteasome pathway inhibitors and related methods The disclosure provides compositions and methods for blocking the proteasome pathway, as well as compounds that block mitotic cell cycle progression. Compounds disclosed include a family of molecules that bind to a multiubiquitin chain attached to a protein and thereby inhibit degradation of that protein by the proteasome pathway. According ... 08/18/05 - 20050182025 - Amidinylphenyl compounds and their use as fungicides Compounds of the formula (R5)m-(R6A)-2-(R4)-1-[N═C(R1)N(R2)(R3)]benzene and their agriculturally suitable salts, are disclosed which are useful as fungicides, wherein R1 is H, OH, SH, SO3H, CN, —OR7 or —SR7; C1-C10 alkyl, C2-C10 alkenyl, C2-C5 alkoxycarbonyl, C2-C10 alkynyl, a C3-C6 carbocycle or a 3-, 4-, 5- or 6-membered heterocycle, each optionally substituted; ... 08/11/05 - 20050176682 - Novel fungicide compositions based on pyridylmethylbenzamide and propamocarb derivative in which the various radicals are as defined in the description, and b) at least one compound (II), which is propamocarb. 2) Method of curatively or preventively combating phytopathogenic fungi in crops, characterized in that an effective, nonphytotoxic amount of one of these fungicidal compositions is applied to the aerial ... // - 1) Fungicidal compositions comprising: - ... 08/04/05 - 20050171059 - Silanol enzyme inhibitors Compounds of formula (I, II, or III), wherein X is OH; Y is OH, H, lower alkyl of one to six carbons or heteroatoms or F; Z and Z′ are independently H, lower alkyl or Q3Si where Q is lower alkyl or aryl; n is 3-50; n′ is 2-50; A ... 07/07/05 - 20050148547 - Fungicidal mixtures based on benzamidoxime derivatives and azoles in a synergistically effective amount are described. ... 06/30/05 - 20050143345 - Cosmetic scar management composition A scar management composition for reducing the cosmetic severity of scars which comprises at least one silicone component, water and at least one thickening agent. ... 06/23/05 - 20050137168 - Heterocyclyl substituted 1-alkoxy acetic acid amides wherein R1 to R6 and A are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor and can be used as medicaments. ... 06/16/05 - 20050130936 - Processes and intermediates for preparing benzyl epoxides where R and PROT are defined herein. These epoxides are useful as intermediates in the production of biologically active compounds, i.e., in the production of pharmaceutical agents. ... 06/09/05 - 20050124579 - Benzyl alcohol derivatives The use of benzyl alcohol derivatives of the formula CH2OH in which R, R2, R3, n and m have the meanings given in claim 1, as microbicidal active substances is described. The compounds exhibit a marked effect against pathogenic Gram-positive and Gram-negative bacteria. They are therefore suitable for the antimicrobial ... 06/02/05 - 20050119225 - Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs wherein R1, R2, R3 and R4 are as defined herein. ... ### FreshPatents.com Support |